Skip to search formSkip to main contentSkip to account menu

Clindamycin 15 MG/ML Oral Solution

Known as: CLINDAMYCIN PALMITATE HYDROCHLORIDE 75 mg in 5 mL ORAL GRANULE, FOR SOLUTION [CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric)], CLINDAMYCIN PALMITATE HYDROCHLORIDE 75 mg in 5 mL ORAL SOLUTION, clindamycin palmitate HCl 75 MG in 5 mL Oral Solution 
National Institutes of Health

Related topics

Related topics

33 relations
Acne VulgarisActinomycetales InfectionsAnti-Bacterial AgentsBacterial Endocarditis

Broader (2)

Clindamycin Oral ProductLincomycins Drug Class

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Improvement of cerebral ischemia/reperfusion injury by daucosterol palmitate-induced neuronal apoptosis inhibition via PI3K/Akt/mTOR signaling pathway
Traditional Chinese medicine has growing importance in the treatment of ischemia stroke due to its abundance and low drug… 
2018
2018
Flow Cytometric Quantification of Fatty Acid Uptake by Mycobacterium tuberculosis in Macrophages.
Mycobacterium tuberculosis (Mtb) has evolved to assimilate fatty acids from its host. However, until recently, there was no… 
2016
2016
Cholesteryl palmitate crystals in bronchoalveolar lavage fluid smears as a possible prognostic biomarker for chronic interstitial pneumonia: A preliminary study.
2016
2016
Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications.
2016
2016
MiR-1271 upregulated by saturated fatty acid palmitate provokes impaired insulin signaling by repressing INSR and IRS-1 expression in HepG2 cells.
2013
2013
Metabolomic Profiling Reveals a Role for Caspase-2 in Lipoapoptosis*
Background: Prior experiments described the metabolic regulation of caspase-2, but the underlying caspase-2-activating stimulus… 
2004
2004
Characteristics of liver targeting Lamivudyl palmitate Solid Lipid Nanoparticles
  • X. Ke
  • 2004
  • Corpus ID: 98861631
Aim To prepare lamivudyl palmitate solid lipid nanoparticles(LAP-SLN) and the nanoparticles modified by a galactoside (LAP-GSLN… 
1992
1992
[Differentiating effect of oral administration of retinol palmitate (Chocola-A) for an aged AML (M3) with severe complications].
A 74 year-old woman, who had been diagnosed as AML (M3) in poor condition, was treated with Retinol Palmitate (Chocola-A, 150,000… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)